Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
Source: WSJ Technology
The Edge of the Cyber World See the latest
Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Source: WSJ Technology